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Drug Repurposing: Tolfenamic Acid
Inactivates PrbP, a Transcriptional
Accessory Protein in Liberibacter
asiaticus
Christopher L. Gardner, Fernando A. Pagliai, Lei Pan, Lora Bojilova, Maria I. Torino,
Graciela L. Lorca* and Claudio F. Gonzalez *
Microbiology and Cell Science Department, Genetics Institute & Institute of Food and Agricultural Science, University of
Florida, Gainesville, FL, USA
CLIBASIA_01510, PrbP, is a predicted RNA polymerase binding protein in Liberibacter
asiaticus. PrbP was found to regulate expression of a small subset of ribosomal genes
through interactions with the β-subunit of the RNA polymerase and a short, specific
sequence on the promoter region. Molecular screening assays were performed to
identify small molecules that interact with PrbP in vitro. Chemical hits were analyzed
for therapeutic efficacy against L. asiaticus via an infected leaf assay, where the
transcriptional activity of L. asiaticus was found to decrease significantly after exposure
to tolfenamic acid. Similarly, tolfenamic acid was found to inhibit L. asiaticus infection
in highly symptomatic citrus seedlings. Our results indicate that PrbP is an important
transcriptional regulator for survival of L. asiaticus in planta, and the chemicals
identified by molecular screening assays could be used as a therapeutic treatment for
huanglongbing disease.
Keywords: transcriptional accessory protein, Liberibacter asiaticus, tolfenamic acid, antimicrobial, citrus
INTRODUCTION
Liberibacter asiaticus is the prevalent causative agent of huanglongbing (HLB; citrus greening),
the most devastating citrus disease worldwide. Since its emergence in the early 1900’s in China,
L. asiaticus has been found in nearly every citrus producing region across the globe, with
devastating consequences (Bove et al., 2006). In the United States, the economic impact of HLB
has already been felt throughout the Florida citrus industry, where estimated losses have exceeded
$9 billion since the pathogen was first detected in 2005; and the California citrus industry is
preparing for similar devastation, as this pathogen continues to spread across the west coast
(Gottwald, 2010).
Liberibacter asiaticus is a phloem-limited pathogen with uneven distribution throughout the
plant. It is transmitted by the Asian citrus psyllid Diaphorina citri and it behaves as intracellular
plant pathogen and as an insect symbiont. These characteristics has made the control and
eradication of L. asiaticus a scientific challenge with no precedents. The lack of stable culturing
conditions for L. asiaticus, in a laboratory setting, has severely hampered progress toward
understanding the physiology and adaptive strategies of this citrus pathogen. Genome analyses
have revealed a drastic reduction of the genetic information encoded by the L. asiaticus genome,
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suggesting this microorganism is highly adapted to life within its
host (Duan et al., 2009). One of the functional protein clusters
suffering the highest negative selection were transcription
factors, which represent only 2% of the total proteins encoded
in the genome (Duan et al., 2009; Pagliai et al., 2014).
Interestingly, the small group of transcription factors preserved
in L. asiaticus includes the gene systematically annotated as
CLIBASIA_01510 (here named PrbP). PrbP is a member of the
CarD_CdnL_TRCF superfamily (CDD cl00588). PrbP shares
low sequence identity with the transcription factor CdnL in
Myxococcus xanthus and with CarD in the Mycobacteriaceae
family (García-Moreno et al., 2010). Members of this protein
family have been linked to pathogenesis, persistence, cell viability,
and resistance to both antibiotics and environmental stress
(Stallings et al., 2009; Stallings and Glickman, 2011; Weiss et al.,
2012).
In absence of laboratory culturing conditions for L. asiaticus,
traditional methods for testing chemicals as antimicrobials
in vivo cannot be applied. In this study, we explored the
possibility of identifying specific ligands in vitro, that affect
the activity of PrbP in vivo, as a means to disrupt gene
expression, and ultimately decrease viability of L. asiaticus
in the citrus host. Only three eukaryotes, Spinacia oleracea,
Beta vulgaris, and Drosophila elegans, were found to carry
PrbP homologs (74, 72, and 46% identity, respectively). The
absence of a PrbP homolog in citrus renders PrbP a unique
target for therapeutics. Furthermore, the use of ligands that
inactivate specific pleiotropic transcription factors, enables
the selective elimination of target species in heterogeneous
populations. Taken together, PrbP represents an excellent
therapeutic target for the design of antimicrobial strategies
against L. asiaticus.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Escherichia coli strains were grown at 37◦C under aerobic
conditions in Luria-Bertani medium (LB) (Difco) or on LB
agar plates. Escherichia coli strains DH5α (Invitrogen, Carlslab,
CA), TOP 10 (Invitrogen), and XL1-Blue (Stratagene, La
Jolla, CA) were used to propagate the plasmids for protein
purification, point mutations, and the two-hybrid system
(the bacterial strains and plasmids used in this study are
listed in Table 1). Escherichia coli strain BL21-Rosetta(DE3)
(Novagen, Gibbstown, NJ) was used for overexpression
and protein purification. When required, the medium was
supplemented with ampicillin (100µg/ml), tetracycline
(10µg/ml), kanamycin (50µg/ml), or chloramphenicol
(25µg/ml). All antibiotics and chemicals were purchased from
Sigma (St. Louis, MO).
Liberibacter crescens BT-1 was cultured at 25◦C with
moderate aeration (150 RPM), in modified BM7 media (Leonard
et al., 2012) containing 1% Brain Heart Infusion (Difco
Laboratories, Detroit, MI), 15% Fetal Bovine Serum (Sigma,
Abbreviations: EMSA, electrophoretic mobility shift assay.
St. Louis, MO), 30% TMN-FH insect medium (Sigma), α-
Ketoglutaric acid (2mg/ml), ACES (10mg/ml), and potassium
hydroxide (3.75mg/ml), at pH 6.9. For determinations of
the antimicrobial activity of metronidazole, dimetridazole,
ronidazole, and tolfenamic acid, each chemical was added to
the liquid media at increasing concentrations (1–500µM). The
optical density was determined at 600 nm every 24 h during
5 days.
DNA Manipulations and Gene Cloning
Standard methods were used for chromosomal DNA isolation,
restriction enzyme digestion, agarose gel electrophoresis,
ligation, and transformation (Pagliai et al., 2010). Plasmids
were isolated using the QIAprep R© Spin Miniprep Kit (Qiagen,
Valencia, CA), and PCR products were purified using Qiaquick R©
Purification Kits (Qiagen). All of the primers used in this study
are described in Table 2. For protein expression and purification,
the prbP (CLIBASIA_01510) gene was amplified by PCR, using
total DNA extractions from L. asiaticus infected tissue, and
cloned into the p15TV-L plasmid as described previously (Pagliai
et al., 2010).
Two-Hybrid System
The two-hybrid system previously described by Borloo et al.
(2007) was used (Borloo et al., 2007). Proteins of interest were
fused to complementing β-galactosidase truncations (1α and
1ω), where the resulting level of complemented β-galactosidase
activity corresponds directly to the level of interaction between
the proteins. Proteins of interests were cloned into vectors
pB2H1α and pB2H1ω using the NotI and BamHI restriction
sites. All subcloning steps were performed in E. coli XL-1 Blue
(Stratagene, La Jolla, CA). Fusion proteins in pB2H1α and
pB2H1ω were transformed by heat shock and subsequently
co-expressed in E. coli TOP10. Empty vectors were used as a
control to determine baseline activity. The minimal inhibitory
concentration (MIC) was determined for each chemical in E. coli
(Table 3). The highest concentration that did not adversely affect
the base levels in the controls was used for subsequent in vivo
assays.
β-Galactosidase Assays
Escherichia coli cells were grown at 37◦C in LB medium
until reaching OD600 of 0.8 (late exponential phase). Cells
were collected and lysed in Z-buffer (60 mM Na2HPO4,
40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 50mM β-
mercaptoethanol; Miller, 1972). β-galactosidase activity was
assayed by following the catalytic hydrolysis of chlorophenol
red-β-D-galactopyranoside (Sigma-Aldrich). The absorbance at
570 nm was read continuously using a Synergy HT 96-well
plate reader (BioTek, Winooski, VT). β-galactosidase activity,
expressed as arbitrary units (AU), was calculated using the slope
of absorbance curve normalized with the initial cell density.
Preliminary β-galactosidase assays were performed with strains
LB01 and LB02, in the absence and presence (0–1mM) of
each chemical to determine baseline activity. Each assay was
performed in triplicates.
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TABLE 1 | Bacterial strains and plasmids used in this study.
Strain or plasmid Genotype or description References
STRAINS
DH5α F− 880lacZ1M15 1(lacZYA-argF) U169 recA1 endA1 hsdR17 (r−K , m
+
K ) phoA supE44 λ– thi-1 gyrA96 relA1 Invitrogen
BL21-Rosetta(DE3) F− ompT hsdS B(r
−
B m
−
B ) gal dcm (DE3) pRARE Novagen
JM109 e14− (McrA−) recA1 endA1 gyrA96 thi-1 hsdR17 (r−K , m
+
K ) supE44 relA1 1(lac-proAB) [F
′ traD36 proAB lacIq
Z1M15]
Promega
TOP10 F− mcrA 1(mrr-hsdRMS-mcrBC) φ80lacZ1M15 1lacX74 nupG recA1 araD139 1(ara-leu)7697 galE15 galK16
rpsL(Strr) endA1 λ−
Invitrogen
LB01 TOP10 carrying empty pB2H1α and pB2H1ω; Ampr; Cmr This work
LB02 TOP10 carrying pB2H1α_prbP and pB2H1ω_rpoB21–150; Amp
r; Cmr This work
LB03 TOP10 carrying pB2H1α_ rpoB21–150 and pB2H1ω_ prbP; Amp
r; Cmr This work
LB04 TOP10 carrying pB2H1α_prbP and pB2H1ω; Ampr; Cmr This work
LB05 TOP10 carrying pB2H1α and pB2H1ω_rpoB21–150; Amp
r; Cmr This work
L. crescens BT-1 Wild type L. crescens strain BT-1 CP003789
PLASMIDS
p15TV-L Expression vector, adds 6X His tag, TEV cleavage site, Ampr EF456736
p15TV-PrbP prbP gene from L. asiaticus cloned in the BseRI site of p15TV-L This work
pB2H1α pACYCDuet-1tac with the E. coli β-galactosidase fragment lacking the sequence for amino acids 11–41 (1α) cloned in
the BamHI-NcoI site; Cmr
Borloo et al., 2007
pB2H1ω pETDuet-11SphItac with the E. coli β-galactosidase fragment lacking the sequence for amino acids 789−1023 (1ω)
cloned in the BamHI−NcoI site; Ampr
Borloo et al., 2007
pB2H1α_prbP pB2H1α with the prbP gene from L. asiaticus cloned in the NotI-BamHI site; Cmr This work
pB2H1α_rpoB21–150 pB2H1α with a portion of the rpoB gene (encoding residues 21–150) from L. asiaticus cloned in the NotI-BamHI site;
Cmr
This work
pB2H1ω_prbP pB2H1ω with the prbP gene from L. asiaticus cloned in the NotI-BamHI site; Ampr This work
pB2H1ω_rpoB pB2H1ω with a portion of the rpoB gene (encoding residues 21–150) from L. asiaticus cloned in the NotI-BamHI site;
Ampr
This work
Kmr , Ampr , Cmr , and Tetr indicate resistant to kanamycin, ampicillin, chloramphenicol, and tetracycline, respectively.
Protein Purification
Protein purification was performed as previously described
(Lorca et al., 2007). Briefly, PrbP was cloned into vector p15TV-
L. The His-tagged fusion protein was then overexpressed in
E. coli BL21-Rosetta(DE3) (Novagen). Cells were grown in LB
broth at 37◦C, to an OD600 of 0.6. Expression was induced with
0.5mM isopropyl -thio-β-D-galactopyranoside (IPTG). After
induction, the cells were incubated at 17◦C for 16 h. The cells
were harvested and resuspended in binding buffer (500mM
NaCl, 5% glycerol, 50mMHEPES, 5mM imidazole, pH 7.5) with
Roche EDTA-free protease inhibitor cocktail (Roche Applied
Science, Germany). Phenylmethylsulfonyl fluoride (0.5mM) and
Tris(2-carboxyethyl)phosphine hydrochloride (0.5mM) were
added to the cells immediately before lysing. Cells were
lysed using a french press. The lysates were clarified by
centrifugation (30min at 17,000× g) and applied to a metal
chelate affinity column charged with nickel. The column was
washed extensively with binding buffer containing 20mM
imidazole, and the proteins were subsequently eluted from
the column with elution buffer (binding buffer containing
250mM imidazole). The purified proteins were dialyzed against
10mM HEPES (pH 7.5), 500mM NaCl, 2.5% glycerol, 0.5mM
TCEP, and stored at −80◦C. The identity of the purified
proteins was confirmed by Mass Spectrometry (as a service
in the Interdisciplinary Center for Biotechnology Research,
University of Florida) from protein bands isolated from SDS-
PAGE gels.
Electrophoretic Mobility Shift Assays
(EMSA)
Gel shift assays for PrbP were performed using aliquots of
protein purified and concentrated according to the procedures
described above. Fragments of the rplK, prbP, rpsJ, dnaK,
and radA promoter regions were generated by PCR using
pre-labeled 5′-biotin primers (Table 2). PCR products were
purified using QIAquick spin columns (Qiagen). EMSA
reaction mixtures (20µL) contained 1 ng of 5′ biotin-labeled
DNA probe, 12.5 ng/µL of both Poly(dI-dC) and Poly(dA-
dT) nonspecific competitor DNAs, 10mM Hepes pH 7.5,
150mM NaCl, 5% glycerol, purified PrbP protein (0–7µM),
and ligand (0–2mM)as indicated. Competition assays were
carried out using unlabeled fragments of the promoter regions
generated by PCR. After incubation at 37◦C for 20min,
samples were separated on 6% acrylamide-bisacrylamide non-
denaturing gels, in ice cold Tris borate-EDTA buffer, pH 8.3
(TBE). Electrophoresis was performed on ice at 100 V for
2 h. DNA was transferred to a Hybond-N+ membrane (GE
Healthcare, Pittsburgh, PA) with a Semi-Dry electroblotter
(Fisher Scientific, Pittsburgh, PA) at 250 mA for 45min.
Transferred DNA was cross-linked to the membrane using
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TABLE 2 | Oligonucleotides used in this study.
Primer Sequence (5′ →3′)
qRT-PCR
CLIBASIA_01510-Fw CTGCCCATGGAGTAGGAACTATTAC
CLIBASIA_01510-Rv ATCTTGTCCTTGTCAAATGCAATAA
CLIBASIA_00120-Fw TGGAGGTGTAAAAGTTGCCAAA
CLIBASIA_00120-Rv CCAACGAAAAGATCAGATATTCCTCTA
CLIBASIA_r05785-Fw TCGAGCGCGTATGCGAATACG
CLIBASIA_r05785-Rv GCGTTATCCCGTAGAAAAAGGTAG
CLIBASIA_00130-Fw TCGGGATCTAAACTTCCTGGT
CLIBASIA_00130-Rv ATAGCCCCCATATCTTGCATC
CLIBASIA_00325-Fw TATCCCAATGTGCTGGTCAA
CLIBASIA_00325-Rv GACCCGTTGCATAAGCATTT
CLIBASIA_00735-Fw CGATGGAGCCAAATCAGACT
CLIBASIA_00735-Rv GGACCTACAATCTGCGAACC
COX-Fw GTATGCCACGTCGCATTCCAGA
COX-Rv GCCAAAACTGCTAAGGGCATTC
18S-Fw GCTTAGGCCAAGGAAGTTTG
18S-Rv TCTATCCCCATCACGATGAA
DNASE I FOOTPRINT
CLIB_00130_Fw_Fam CTGATGGTCCGTTTGCTTCT
CLIB_00130_Rv_Vic TGCAGAACCCGACTCTATCTG
EMSA
EMSA_CLIB_00130_Ext_Fw CTGTTTTCTTCGAGGTTGGTG
EMSA_CLIB_00130_Ext_Rv CCGCATTAAACGCCTTACAA
EMSA_CLIB_00130_Fw CTGATGGTCCGTTTGCTTCT
EMSA_CLIB_00130_Rv_Bio TGCAGAACCCGACTCTATCTG
EMSA_Cold_CLIB_00130_Rv TGCAGAACCCGACTCTATCTG
EMSA_CLIB_01510_Fw_Bio TCTAAACCCTTGGCGCATC
EMSA_CLIB_01510_Rv TGAAAAGTATTTCTCCCCTAATCC
EMSA_Cold_CLIB_01510_Fw TCTAAACCCTTGGCGCATC
EMSA_CLIB_RadA_Ext_Fw GTCTTGTGGCGTTTCACATC
EMSA_CLIB_RadA_Ext_Rv CAGAAGCAAGGGCTACATCA
EMSA_CLIB_RadA_Fw TCATCTTGCTTGTGCTGATG
EMSA_CLIB_RadA_Rv_Bio GGCTATCAGACTATCGCGTGT
EMSA_Cold_CLIB_RadA_Rv GGCTATCAGACTATCGCGTGT
EMSA_CLIB_DnaK_Ext_Fw TGTCTCCGTATCAACTGCAA
EMSA_CLIB_DnaK_Ext_Rv ACTGTTTTCCCTGTGCTTCG
EMSA_CLIB_DnaK_Fw AATTTTTCCTTGCAATCAAGC
EMSA_CLIB_DnaK_Rv_Bio TCCATAATAGCAACGCATGAA
EMSA_CLIB_RpsJ_Ext_Fw TGCTCCTGGTTCGATTCAA
EMSA_CLIB_RpsJ_Ext_Rv CCGCATTTCCAATTGATCTC
EMSA_CLIB_RpsJ_Fw CGATGGAGCCAAATCAGACT
EMSA_CLIB_RpsJ_Rv_Bio GGACCTACAATCTGCGAACC
EMSA_CLIB_r05785_Fw AGAAGAAAGGGAGACGTGGA
EMSA_CLIB_r05785_Rv CCATGCGTTATCCCGTAGAA
SITE DIRECTED MUTAGENESIS
rplKM1_Fw GTGTTTGTTTTATATAGTCGGTTGGTTGTTTTTTAG
rplKM1_Rv CTAAAAAACAACCAACCGACTATATAAAACAAACAC
rplKM2_Fw GTGTTTGTTTTATATAGTATATTGGTTGTTTTTTAG
rplKM2_Rv CTAAAAAACAACCAATATACTATATAAAACAAACAC
rplKM3_Fw GTTTTATATAGTAGGCCGGTTGTTTTTTAGAAAGG
(Continued)
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TABLE 2 | Continued
Primer Sequence (5′ →3′)
rplKM3_Rv CCTTTCTAAAAAACAACCGGCCTACTATATAAAAC
rplKM4_Fw GTTTTATATAGTAGGTTAATTGTTTTTTAGAAAGGCTAGG
rplKM4_Rv CCTAGCCTTTCTAAAAAACAATTAACCTACTATATAAAAC
rplKM5_Fw GTTTTATATAGTAGGTTGGCCGTTTTTTAGAAAGGCTAGGG
rplKM5_Rv CCCTAGCCTTTCTAAAAAACGGCCAACCTACTATATAAAAC
rplKM6_Fw GTTTTATATAGTAGGTTGGTTGCCTTTTAGAAAGGCTAGGG
rplKM6_Rv CCCTAGCCTTTCTAAAAGGCAACCAACCTACTATATAAAAC
rplKM7_Fw GTTTTATATAGTAGGTTGGTTGTTCCTTAGAAAGGCTAGGGATGGC
rplKM7_Rv GCCATCCCTAGCCTTTCTAAGGAACAACCAACCTACTATATAAAAC
rplKM8_Fw GTGTTTGTTTTATATAATAGGTTGGTTGTTTTTTAG
rplKM8_Rv CTAAAAAACAACCAACCTATTATATAAAACAAACAC
rplKM9_Fw GTAGGTTGGTTGTTTTTTATAAAGGCTAGGGATGGC
rplKM9_Rv GCCATCCCTAGCCTTTATAAAAAACAACCAACCTAC
rplKM10_Fw GGTTGGTTGTTTTTTAGCCAGGCTAGGGATGGCAAAG
rplKM10_Rv CTTTGCCATCCCTAGCCTGGCTAAAAAACAACCAACC
rplKM11_Fw GGTTGGTTGTTTTTTAGACCGGCTAGGGATGGCAAAG
rplKM11_Rv CTTTGCCATCCCTAGCCGGTCTAAAAAACAACCAACC
rplKM12_Fw GGTTGGTTGTTTTTTAGAAATGCTAGGGATGGCAAAG
rplKM12_Rv CTTTGCCATCCCTAGCATTTCTAAAAAACAACCAACC
TWO-HYBRID CONSTRUCTS
prbP-Fw tattgcggccgcATGACATTCCAACAGAAAAGAGATG
prbP-Rv tatatggatccTGCGGCTTTATCTTGATTTTCGCTT
rpoB_Ext-Fw CGTTGTGTTCAATGGTCTCG
rpoB_Ext-Rv GGAACCTTGCGACGTCTATC
rpoB-Fw tattgcggccgcCCTGAGATAATTGACATACCTGATCT
rpoB-Rv tatatggatccCTGAATACCC TTAATAACGA AAGTTCC
OVEREXPRESSION AND PROTEIN PURIFICATION IN p15TV-L
CLIBASIA_01510_LIC-Fw TTGTATTTCCAGGGC ATGACATTCCAACAGAAAAGAGATG
CLIBASIA_01510_LIC-Rv CAAGCTTCGTCATCA CTATGCGGCTTTATCTTGATTTTC
CLIBASIA_01510_Ext-Fw GAGTGTGCGTTTGTTTGAAAAG
CLIBASIA_01510_Ext-Rv CCCACGCGATCTTATCTGAC
Restriction sites are underlined.
a Spectrolinker XL-1000 UV cross-linker equipped with
312 nm UV bulbs. Biotin labeled DNA was detected using
a Phototope-Star Detection Kit (New England Biolabs,
Ipswich, MA). Membranes were exposed to Kodak X-ray
film.
DNase I Footprinting
Protection assays were performed on both minus and plus
strands using 5′-6FAM or 5′-VIC labeled probes that were
generated by PCR (primers described in Table 2). 1.5µg of
labeled PrplK probe was combined with 40µM PrbP, 0.5mM
CaCl2, 2.5 mM MgCl2, and 0.025 U of DNase I (New England
Biolabs) in a 200µl reaction. After incubation at 37◦C for 20min,
the reaction was stopped by the addition of 50 mM EDTA, pH
8.0. As a control, a digestion reaction was performed under
the same conditions without PrbP. The digested DNA and the
sequencing reaction products were analyzed at the Plant and
Microbe Genomics facility, Ohio State University, Columbus,
using a 3730DNA analyzer. The protected regions were identified
using GeneMapper software (Life Technology), as previously
described (Zianni et al., 2006).
Small Molecule Screening by Differential
Scanning Fluorimetry
Purified PrbP protein was screened against the Prestwick
chemical library of 1152 compounds (Prestwick Chemical,
France) using differential scanning fluorimetry as previously
described (Vedadi et al., 2006; Niesen et al., 2007; Wrench
et al., 2013). Briefly, purified PrbP protein was diluted to a final
concentration of 20µM in 100mM HEPES, pH 7.5, 150mM
NaCl. 20µl aliquots of a protein solution containing the chemical
compounds were placed in duplicate, into 96-well plates (Bio-
Rad) and heated from 25 to 80◦C, at the rate of 1◦C per min.
A real time PCR device (iCycler IQTM, Bio-Rad) was used to
monitor protein unfolding by an increase in the fluorescence
of the fluorophore SYPRO Orange (Invitrogen). Fluorescence
intensities were plotted against temperature for each sample well,
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TABLE 3 | Small molecules used in this study.
Chemical 1Tma MICb Concentrationc β-galactosidase activityd
(◦C) (µM) tested (µM) (% decrease)
Berberine 1.5 100 50 5.1±0.6
Acetazolamide 1.7 >200 50 3.7±0.4
Metronidazole 1.8 100 50 53.7±10
Gramine −2.5 100 40 15.3±0.3
Cotine 2.1 50 10 5.2±0.8
Tolfenamic
acid
−4.2 100 25 17.5±5.3
Folic acid −3.5 >400 200 2.2±0.2
Menadione −2.5 50 15 9.8±2.3
2-Methyl-4(5)-
nitroimidazole
ND >200 100 17.5±0.2
Ornidazole 0.5 50 10 11.6±2.4
Dimetridazole ND 50 10 25.8±4.6
1,2-
Dimethylimidazole
ND >200 200 37.6±6.1
Ronidazole ND 10 1 48.2±3.9
The effect of small molecules on the thermal stability of PrbP (∆Tm) and on interactions
between PrbP and RpoB (β-galactosidase activity).
a∆Tmwas calculated as the difference in the transition temperature of PrbP in the absence
(PrbP Tm = 37.3◦C) and presence of each chemical. The results are the average of
duplicates.
bMIC: Minimal Inhibitory Concentration for the E. coli TOP10 reporter strain.
cConcentration tested: Concentration used in the bacterial two-hybrid system.
dβ-galactosidase activity (expressed as arbitrary units, AU) as a result of pB2H∆α-prbP
and pB2H1ω-rpoB21–150 interaction is expressed as a decrease in the activity in the
presence of chemicals, compared to the control without chemicals after 240 min (OD =
0.8). The assay was performed a minimum of three times, each in triplicates.
and transition curves were fitted with the Boltzmann equation
using Origin 8 software (Northampton, MA). The midpoint of
each transition was calculated and compared with the midpoint
calculated for the reference sample. If the difference between the
midpoints was greater than 2.0◦C, the corresponding compound
was considered to be a “hit.”
Analyses of Chemicals on Infected Leaves
Leaves were collected from HLB-symptomatic Valencia Orange
(C. sinensis) trees, maintained at the University of Florida main
campus. All leaves used in this study were collected from new
flushes on highly symptomatic branches. Prior to treatment all
solutions were autoclaved or filter sterilized. 100µM stocks of
the chemical were prepared in 10mM Tris pH 8.0. A solution
of 10mM Tris pH 8.0 was used for the controls. A scalpel was
used to harvest leaves from the tree, with a horizontal cut at
the base of the petiole. Each leaf was immediately suspended
in 8ml of treatment solution (with or without chemicals).
Leaves were supported in a vertical position throughout the
incubation period, with only the lower inch of the petiole
submerged in solution (with or without chemical). Steady air flow
was maintained over the leaf blades throughout the incubation
period, to facilitate transpiration and the adsorption of each
solution. Each treatment group consisted of 12 leaves that were
processed after 24 h of incubation (with or without chemical).
For each treatment group, biological quadruplicates were
prepared from the twelve leaves. The leaf midribs and petioles
were collected and incubated overnight at 4◦C in RNAlater
solution (Life Technologies, Grand Island, NY). Following
treatment with RNAlater, samples were rinsed twice with RNase
free water and immediately frozen in liquid nitrogen. Samples
were then freeze dried over a period of 3 days and homogenized
using a GenoGrinder 2000. Homogenized samples were stored
at−80◦C.
RNA Purification and cDNA Synthesis
Plant and bacterial RNA was extracted from 75mg of
homogenized tissue. Extractions were carried out using the
Isolate II RNA Plant Kit (Bioline, London, UK) with lysis
buffer RLY. Zirconia beads (0.1mm) were added to each sample
during lysis, to aid with the disruption of bacterial cells. Purified
RNA was eluted with 60µl of RNase/DNase-free water, and
subsequently treated with TURBO DNA-free DNase (Thermo
Scientific, Wilmington, DE) to eliminate trace amounts of
DNA. Purified RNA samples were quantified using a NanoDrop
ND 1000 (Thermo Scientific, Wilmington, DE) and stored at
−80◦C. cDNA was synthesized using the iScript cDNA Synthesis
Kit (Bio-Rad, Hercules, CA) with random hexamer primers
and 0.5µg of RNA. cDNA products were diluted 50% with
DNase/RNase-free water and stored at−80◦C.
Real-Time Quantitative PCR (qRT-PCR)
Analysis
qRT-PCR was carried out in a iCycler IQ apparatus (Bio-Rad)
using Platinum SYBR Green qPCR SuperMix for iCycler
(Life Technologies) in accordance with the manufacturer’s
recommended protocol. Reactions were carried out using
2µl of cDNA, in a total reaction volume of 26µl. The genes
measured for L. asiaticus included prbP (CLIBASIA_01510),
L25 (CLIBASIA_01515), rplK (CLIBASIA_00130), rpsJ
(CLIBASIA_00735), gyrA (CLIBASIA_00325), and 16S
rRNA (CLIBASIA_r05785). The mRNA levels of rplK,
CLIBASIA_r05785, rpsJ and prbP genes were normalized to
the abundance of the plant genes cox2 and 18S rRNA. The
expression of each plant control gene was previously examined
in absence and presence of tolfenamic acid (data not shown).
Quantitative reverse transcription-PCR primers are described in
detail in Table 2.
Evaluation of Phytotoxicity on Sweet
Orange Seedlings
Twelve-month old seedlings were randomly divided into ten
groups of 8 seedlings. Tolfenamic acid was prepared in 10 mM
tris buffer, and applied at concentrations of 1, 10, 100, 1000,
and 10,000 µM by root soaking (with 100 ml), foliar spray
(to saturation), or root soaking and foliar spray combined. A
control group was also treated with 10mM tris buffer only. Each
treatment was applied twice at 2 week intervals. A non-treated
control group was also maintained throughout the duration
of the experiment. Seedlings were monitored for symptoms of
phytotoxicity during a period of 12 months following treatment.
No phytotoxic effects were observed following treatment with
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tolfenamic acid (up to 10mM). Tolfenamic acid had no
effect on the transcription of Cox2 or 18S rRNA (data not
shown).
Evaluation of Antimicrobial Efficacy of
Tolfenamic Acid against L. asiaticus
Citrus sinensis “Valencia” inoculation: Twelve-month old
seedlings were graft inoculated with budwood collected from
HLB-infected trees. Prior to grafting, the source of the infected
tissue was analyzed by PCR to confirm the presence of viable L.
asiaticus. PCR confirmation was carried out using primers for
16S rRNA (CLIBASIA_r05781) and gyrA (CLIBASIA_00325)
genes (see Table 2 for primer sequences). Inoculated plants were
kept in a secure greenhouse approved by the USDA Animal
and Plant Health Inspection Service (APHIS). The plants were
watered in accordance with the standard watering schedule
for the commercial citrus industry. Citrus fertilizer (Sunniland
Citrus 6-4-6, N-P-K) was applied every 2 months as instructed
by the manufacturer. Two months after grafting, each plant was
tested for HLB by PCR as described above.
Seedlings treatment study: After 9 months of testing positive
for HLB, the highly symptomatic, infected sweet orange seedlings
(described above) were randomly divided into two groups.
100µM tolfenamic acid (TA) was applied to one group of
infected seedlings as a foliar spray (to saturation), and by root
soaking (with 100ml of 100 µM TA). The buffer vehicle (10mM
tris) was applied to the control group as a foliar spray (to
saturation), and by root soaking (with 100ml of 10mM tris).
Each treatment was applied twice, at 2 week intervals. Evaluation
of HLB symptoms (leaf yellowing and mottling) and L. asiaticus
transcriptional activity (as a measure of viability) was performed
as described above.
Statistical Analyses
qRT-PCR statistical significance was assessed using a two-tail
P-value, calculated with the Mann–Whitney nonparametric test.
RESULTS
PrbP Binds Specifically to the Promoter
Region of rplK
Previous studies in PrbP homologs have found that these
proteins may bind non-specifically to the promoter regions
of the rrnA, and rpsH genes (Gulten and Sacchettini, 2013;
Srivastava et al., 2013). In this study, we examined the
DNA binding properties of PrbP in L. asiaticus, using the
promoter region of genes encoding the ribosomal proteins rplK
(CLIBASIA_00130; PrplK) and rpsJ (CLIBASIA_00735; PrpsJ), as
well as the promoter regions of 16S rRNA (CLIBASIA_r05785;
P16S), prbP (CLIBASIA_01510; PprbP), dnaK (CLIBASIA_02620;
PdnaK), and radA (CLIBASIA_01095; PradA). We found that PrbP
was able to bind PrplK at 3.5 µM and P16S at 5 µM, while
binding to PrpsJ , PprbP, PdnaK , and PradA was only observed
with higher concentrations (10–15 µM) of PrbP (Figure 1).
Competition assays were used to confirm the specificity of
the PrbP:PrplK interaction, where a 10-fold excess of unlabeled
PrplK was found to completely out-compete the labeled PrplK
fragment (Figure 2). At higher concentrations (100–400-fold
excess), PdnaK was found to compete with the labeled PrplK
fragment, but to a lesser extent than observed with unlabeled
PrplK . The addition of excess (up to 400-fold) unlabeled PradA or
unlabeled PprbP had no effect (Figure 2). These results indicate
that PrbP binds to a specific sequence in the promoter region
of rplK, with higher affinity. DNase I footprinting was used
to identify the DNA binding site for PrbP in the promoter
region of rplK (Figure 3A). The 24 nucleotide protected site
(GTAGGTTGGTTGTTTTTTAGAAAG), is located 31 bp from
the translational start codon, on the plus strand. The critical
DNA contact residues were identified by EMSA analysis,
following site directed mutagenesis of the rplK promoter region
(Figures 3B,C). Of the twelve mutant EMSA probes tested, only
rplK-M1, rplK-M4, rplK-M5, rplK-M10, and rplK-M11 resulted
in decreased binding to PrbP (Figure 3C). These results indicate
that nnAnnnnGGTTnnnnnnnnnAAAn is the PrbP recognition
sequence for this promoter. These results confirm that L. asiaticus
PrbP interacts with a specific sequence in the promoter
region.
Liberibacter asiaticus PrbP Interacts with
the β-Subunit of the RNA Polymerase
A bacterial two-hybrid system was used to investigate potential
interactions between PrbP and the β-subunit of the RNAP.
Plasmids pB2H1α and pB2H1ω were used to create
fusions of the L. asiaticus genes CLIBASIA_01510 (prbP)
and CLIBASIA_0011021–150 (rpoB, residues 21–150), to the
β-galactosidase truncations 1α and 1ω as described by Borloo
et al. (2007). Protein-protein interactions were followed by
β-galactosidase activity. High levels of β-galactosidase activity
were observed in strains LB02 (carrying pB2H1α-prbP and
pB2H1ω-rpoB21–150) and LB03 (carrying pB2H1α-rpoB21–150
and pB2H1ω-prbP) (5823 ± 345 AU and 3252 ± 217AU,
respectively), when compared to the control strains (Figure 4).
These results confirm that L. asiaticus PrbP interacts with the
RNAP.
Identification of Small Molecules That Bind
PrbP
Our approach to study the biological role of PrbP was to identify
small molecules that bind and/or interact with the protein to
regulate its activity. To this end, the L. asiaticus prbP gene was
cloned into vector p15TV-L, and subsequently overexpressed
in E. coli BL21. The purified protein was screened against the
Prestwick chemical library of small molecules, by differential
scanning fluorimetry (Vedadi et al., 2006; Pagliai et al., 2010;
Wrench et al., 2013). The midpoint transition temperature of
PrbP was determined to be 37.3 ± 0.5◦C. From the 1200 small
molecules examined in the screening, 8 compounds were found
to induce a shift in themidpoint transition temperature (1Tm) of
PrbP. Metronidazole, cotine, gramine, menadione, folic acid, and
tolfenamic acid were found to have the strongest effect, inducing
a Tm shift of 1.8◦, 2.1◦, −2.5◦, −2.5◦, −3.5◦, and −4.5◦C,
respectively (Table 3). Berberine chloride and acetazolamide
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FIGURE 1 | DNA binding assays with PrbP. EMSAs were conducted with 1 ng of biotin labeled probes PrplK , P16S, PrpsJ, PprbP, PdnaK , or PradA and increasing
concentrations (0–15 µM) of PrbP, as indicated on top of each panel. No protein was added to the first lane of each gel.
were found to interact with PrbP to a lesser degree, with a ∆Tm
of 1.5◦ and 1.7◦C, respectively.
Small Molecules Modulate PrbP
Interactions with the RNA Polymerase
A bacterial two-hybrid system was used to further investigate
the interactions between PrbP and RNAP, in the absence and
presence of each chemical. The MIC was determined for each
chemical in E. coli (Table 3). Preliminary β-galactosidase assays
were performed using strains LB01 and LB02, in absence
and presence (1µM−1 mM) of each chemical to determine
baseline activity. The highest concentration that did not adversely
affect the base levels in the controls was used for subsequent
in vivo assays (Table 3). Metronidazole showed the strongest
effect, decreasing PrbP/RpoB interactions by 53.7%, while
berberine, acetazolamide, gramine, cotine, menadione, folic
acid, and tolfenamic acid had a lesser effect, decreasing the
interaction by 5.1, 3.7, 15.3, 5.2, 9.8, 2.2, and 17.5%, respectively
(Table 3).
Consequently, we identified five compounds with chemical
scaffolds similar to metronidazole (dimetridazole, 2-methyl-
4(5)-nitroimidazole, 1,2-dimethylimidazol, ornidazole, and
ronidazole) and their effect was tested on the interaction
between PrbP and RpoB. The inhibition values obtained were
low for ornidazole (11.6%), 2-methyl-4(5)-nitroimidazole
(17.5%), and dimetridazole (25.8%). When tested at higher
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FIGURE 2 | PrbP binds specifically to rplK promoter region. For competition experiments, a biotin labeled PrplK probe was incubated with 2.5 µM PrbP and
mixed with increasing concentrations (1–400 ng) of an unlabeled, double stranded probe (PrplK , PprbP, PradA, or PdnaK ), as indicated above each panel.
concentrations (200 µM), 1,2-dimethylimidazole was found to
decrease PrbP/RpoB interactions by 37.6%, however, no effect
was observed at lower concentrations (<50 µM). Conversely,
a lower concentration (1µM) of ronidazole was found to
significantly decrease (48%) PrbP/RpoB interactions (Table 3).
Small Molecules Disrupt Interactions
between PrbP and DNA
EMSA were performed with PrbP in the presence and absence
of the small molecules identified by differential scanning
fluorimetry. The promoter region of rplK (PrplK) was used
as the target DNA in all assays. Of the compounds tested,
tolfenamic acid was the only effective inhibitor of interactions
between PrbP and PrplK (Figure 5A). Complete disruption of
the PrbP:PrplK complex was observed with 350µM tolfenamic
acid (Figure 5B). Metronidazole, ronidazole, acetazolamide,
gramine, cotine, menadione, and folic acid had no effect on
the PrbP:PrplK complex when present at concentrations up
to 2mM.
Small Molecules as Therapeutics against
L. asiaticus
As propagation of L. asiaticus still remains elusive under
laboratory conditions, we used the culturable close relative
L. crescens to determine the antimicrobial activity of
metronidazole, dimetridazole, ronidazole, and tolfenamic
acid. It was found that metronidazole, dimetridazole and
ronidazole were not inhibitory at concentrations up to 500
µM. When combined with the results of the bacterial two
hybrid system, these results suggest that interactions between
PrbP and RNAP may not be critical for the persistence of
L. crescens under the conditions tested. Conversely, growth
inhibition of L. crescens was observed in presence of tolfenamic
acid (70µM), indicating interactions between PrbP and
DNA are indeed essential for the survival of L. crescens
(Figure 6).
An infected leaf assay was used to assess the efficacy of
tolfenamic acid against L. asiaticus, in vitro (Pagliai et al.,
2014). Leaves were collected from Valencia Orange (C. sinensis)
trees infected with L. asiaticus. Upon collection, leaves were
immediately immersed in 1, 10, or 100 µM tolfenamic acid.
Following incubation, each sample was analyzed by qRT-PCR
to determine the relative change in gene expression for 16S
rRNA, DNA gyrase subunit A, L10 ribosomal, PrbP and RplK
protein (encoded by CLIBASIA_r05785, gyrA, rplJ, prbP, and
rplK, respectively) as viability parameters for L. asiaticus (Pagliai
et al., 2014). Due to the variability in bacterial load, samples
were normalized to the plant gene cox2 and 18S rRNA. Samples
incubated with 10 or 100 µM tolfenamic acid showed a
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FIGURE 3 | Identification of PrbP binding site in rplK promotor (PrplK ). (A) DNAse I footprint assays identified a protected site (red) located 31 bp from the rplK
translation start site. The electropherogram shows a fragment of the digested probe in absence (white) or presence (black) of PrbP, highlighting the protected region.
(B) Site directed mutagenesis of the rplK promoter region. Mutated residues are indicated (in red) for each of the rplK mutants (rplK-M1–rplK-M12). (C) EMSA assays
were conducted using 1 ng of each mutant PrplK probe (rplK-M1–rplK-M12) with increasing concentrations (0–7 µM) of PrbP, as indicated on top of each panel. The
amount of free PrplK was used to determine the binding efficiency of PrbP with each mutant probe.
significant (p < 0.05) decrease in the expression of all five genes
(Figure 7). These results suggest that tolfenamic acid may be
inhibitory to L. asiaticus at 10 and 100 µM.
The addition of 1 µM tolfenamic acid did not have a
significant effect on the expression levels of gyrA, prbP, or
rplJ, however, a significant (p < 0.005) decrease in expression
was observed for rplK and 16S rRNA (93 and 77% reduction,
respectively). These results indicate that PrbP is a transcriptional
activator for rplK and the 16S ribosomal genes in L. asiaticus.
Additionally, these results indicate that expression of prbP is
not auto-regulated at the level of transcription, in a manner
dependent on DNA binding.
Use of Tolfenamic Acid as Antimicrobial in
HLB-Infected Citrus Seedlings
Prior to testing the efficacy of tolfenamic acid in L. asiaticus
infected citrus trees, a phytotoxicity assessment was performed
using healthy 12 month-old citrus seedlings. Following 6 months
of treatment with tolfenamic acid (1, 10, and 100µM), no
phytotoxic effects were observed in any of the treatment groups.
The efficacy of tolfenamic acid was subsequently determined in
L. asiaticus-infected citrus seedlings (Citrus sinensis, “Valencia”).
Seedlings were infected with L. asiaticus (via grafting) and
maintained in a greenhouse for 12 months to allow the infection
to spread throughout the entire plant. Each plant had symptoms
of advanced L. asiaticus infection and the presence of L. asiaticus
was confirmed by PCR prior to beginning treatments with
tolfenamic acid (Figures 8, 9).
Tolfenamic acid (100µM) was administered to infected
seedlings via root soaking and as a foliar spray (to saturation).
Two applications were made over a period of 2 weeks.
Four infected seedlings were also maintained under the
same conditions as a control. Each plant was examined and
photographed every 2 weeks to monitor the canopy and root
tissue for signs of recovery or disease progression. New root
tissue was observed in several of the treated plants 2 weeks after
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FIGURE 4 | Analysis of PrbP interactions with RpoB. β-galactosidase activity was performed using E. coli TOP10 derivatives as reporter strains, transformed with
the following plasmid combinations: LB01 (1) carrying the empty pB2H1α and pB2H1ω plasmids; LB02 (♦) carrying pB2H1α_prbP and pB2H1ω_rpoB21–150);
LB03 () carrying pB2H1α_rpoB21–150 and pB2H1ω_prbP; LB04 ( ) carrying pB2H1α_prbP and the empty pB2H1ω; and LB05 (O) carrying the empty pB2H1α
and pB2H1ω_rpoB21–150. Assays of β-galactosidase activity are expressed in arbitrary units (AU), and were performed at different growth phases (as indicated by
optical density, A600), in triplicates. The β-galactosidase activity for each strain was quantified after subtraction of the baseline activity.
FIGURE 5 | Small molecules decrease PrbP binding to PrplK . (A) EMSAs were conducted with the biotin labeled probe Prplk (1 ng) and PrbP (2.5 µM), in the
absence (lane 2; None) and presence of 2 mM metronidazole, acetazolamide, gramine, cotine, tolfenamic acid, menadione, or folic acid. DMSO (5% final
concentration) was ran as a solvent control (lane 3). No protein was added to the first lane. (B) EMSAs were conducted with probe PrplK (1 ng) and increasing
concentrations (0–500 µM) of tolfenamic acid, as indicated on top of the panel. PrbP was maintained at 2.5µM. No protein was added to the first lane.
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FIGURE 6 | The effect of tolfenamic acid on Liberibacter crescens
growth. L. crescens BT-1 was cultured at 25◦C with moderate aeration (150
RPM), in modified BM7 media, with increasing concentrations (0–70µM) of
tolfenamic acid as indicated: (♦) Control without TA; () 1 µM TA; (1) 10 µM
TA; (X) 50 µM TA; (O) 70 µM TA. Bacterial growth was determined by optical
density at 600 nm (A600), over a period of 5 days.
FIGURE 7 | Tolfenamic acid modulates the activity of PrbP in vivo. The
effect of tolfenamic acid on the transcriptional activity of L. asiaticus. The
expression levels of gyrA, rplJ, 16S RNA, prbP and rplK were assessed after
24 h. Tolfenamic acid (TA) was tested at increasing concentrations (0–100 µM)
as indicated: (red) 1 µM TA, (green) 10 µM TA, (magenta) 100 µM TA. Control
samples (blue) were treated with buffer only. (*p < 0.05; **p < 0.005). The plant
gene cox2 was used to normalize the expression values between samples.
treatment. Twomonths after treatment, healthy new flush growth
began to push on several of the treated plants, and continued to
grow over the next 11 months with no visible signs of infection
(Figure 8). Eleven months after treatments were applied, three of
the four plants treated with tolfenamic acid showed clear signs of
recovery in both root and canopy tissues (Figure 8). In contrast,
in the control group treated with the buffer vehicle only, three out
of the four plants died (Figure 9). In the treated plants, qRT-PCR
analysis of root tissue revealed the absence of L. asiaticus infection
in plants TA-1, TA-2, and TA-3 while plant TA-4 showed
only a 10% reduction in the expression of rplJ (Figure 10). A
significant drop (80–95% reduction) in L. asiaticus titer was
also observed in the canopy tissue of 75% of the treated plants
(Figure 10).
DISCUSSION
Due to the extended timeframe and financial obligations
associated with the development and approval of new therapeutic
compounds, drug repurposing has become an appealing
approach to drug discovery; the availability of pharmacokinetic
and pharmacodynamic data can significantly reduce research
costs, and expedite the approval process. For these reasons,
we elected to use a library of FDA approved compounds as
a starting point for screening protein targets. The absence of
putative pathogenicity determinants in L. asiaticus, prompted
the investigation of unconventional proteins as targets for the
development of therapeutic strategies against this devastating
pathogen. The in silico analyses revealed a small number of
simple regulatory mechanisms in the L. asiaticus genome, which
enable its survival during the changing growth conditions
encountered in two remarkably different hosts, the psyllid and
the citrus plant. As a consequence, the transcriptional regulation
of several metabolic pathways must be achieved with only
a few transcription factors. Based on these observations, the
inactivation of a transcription factor may result in pleiotropic
effects, influencing the ability for L. asiaticus to survive within
the citrus host.
CarD, a low identity homolog to PrbP, is an essential RNA
polymerase binding protein in Mycobacterium species. It is
involved in pathogenesis, persistence, cell viability, and resistance
to both antibiotics and stress (Stallings et al., 2009; Srivastava
et al., 2013). CarD interacts with both the β-subunit of the RNA
polymerase and, non-specifically, with DNA sequences in the
promoter region of several genes (Srivastava et al., 2013). In
L. asiaticus, PrbP also showed interaction with RNAP and DNA.
We also found that PrbP was capable of differentially binding the
rplK promoter. The putative binding site in the rplK promoter
is located 31 bp upstream from the translation start site. This
binding location is in agreement with the role of PrbP as a
transcriptional activator that may function to stabilize the open
promotor complex.
The transcription of rRNA is one of the rate-limiting steps
controlling cell growth under ideal and stress conditions;
during this process, formation of stable RNAP/open-promotor
complexes is the most time consuming step (Zhou and Jin,
1998; Bartlett et al., 2000; Jin et al., 2012; Häkkinen et al.,
2013). In Mycobacterium, CarD was recently found to increase
the formation of RNAP/open promoter complexes, and
stabilize RNAP open complexes by preventing transcription
bubble collapse (Davis et al., 2015; Rammohan et al.,
2015). Point mutations in CarD that weaken interactions
with RNAP are detrimental in M. tuberculosis, resulting in
reduced viability and increased sensitivity to antibiotics and
oxidative stress (Weiss et al., 2012). As such, we hypothesized
that the inactivation/inhibition of PrbP would cause a
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FIGURE 8 | Tolfenamic acid is an effective antimicrobial compound against L. asiaticus in HLB-infected citrus seedlings. Recovery of root and canopy
tissue in L. asiaticus-infected seedling TA-2 (upper panel) after treatment with 100 µM tolfenamic acid. The canopy and root tissue was photographed before
treatment with tolfenamic acid, 2 weeks after treatment, 2 months after treatment, and 11 months after treatment. L. asiaticus-infected seedlings TA-1, TA-3, and
TA-4 are shown in the lower panel. Photographs were taken before treatment began and 11 months after treatment.
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FIGURE 9 | Photographs of control seedlings (n = 4) treated with buffer
vehicle (10mM Tris, 0.1% DMSO). Seedlings were photographed before
treatment began, and post treatment (for up to 11 months).
decrease in transcript production in L. asiaticus, potentially
resulting in decreased viability and persistence within the
host.
FIGURE 10 | Gene expression in leaf and root tissue 11 months after
treatment with tolfenamic acid. L. asiaticus mRNA levels for rplJ (blue) and
gyrA (red) were determined in fresh tissue collected from treated seedlings
(TA-1, TA-2, TA-3, and TA-4) and compared to the untreated controls. The
plant gene cox2 was used to normalize the expression values between
samples. The lower mRNA expression levels observed in treated plants are
indicative of reduced L. asiaticus infection. No amplification was observed in
root samples from plants TA-1, TA-2, and TA-3.
While several compounds were found to modulate
interactions between PrbP and RNA polymerase, tolfenamic acid
was the only small molecule that decreased interactions between
PrbP and DNA (Figure 5). The effect of these chemicals was also
tested in vivo, where tolfenamic acid was found to be the only
small molecule that affected the overall transcriptional activity
of L. crescens. The results suggest that the ligand specificity for
disruption of the PrbP:PrplK complex is more stringent than the
binding specificity for ligands that disrupt interactions between
PrbP and RNAP.
To confirm the effect of tolfenamic acid in planta, tolfenamic
acid was applied by root soaking and foliar spray to L. asiaticus
infected citrus seedlings in a greenhouse setting. Each seedling
was confirmed to harbor viable, L. asiaticus cells for at least
6 months prior to beginning treatment. In addition to testing
positive for L. asiaticus, each plant also displayed severe signs
of infection, including blotchy mottle, yellowing shoots, and
severe damage to the root system. After the initial treatment, the
first sign of recovery in treated seedlings was the development
of new root growth. Rapid recovery of the root system was
observed in 75% of seedlings that were treated with tolfenamic
acid (Figures 8, 10). Although several plants showed improved
root growth in as little as 14 days after treatment, the canopy
tissue was slower to recover (5–11 months before substantial
amounts of new growth was observed).
The extent of vascular damage caused by the presence of
L. asiaticus may affect the rate that compounds (chemical
treatments) are distributed throughout the canopy, and thus the
rate at which each plant recovers. Previous studies have shown
that HLB significantly affects the vascular flow and exchange
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of nutrients between root and canopy tissue (Etxeberria et al.,
2009; Koh et al., 2012). Factors contributing to the reduction in
vascular flow include the accumulation of starch within the xylem
and phloem, the blockage of sieve elements by callose formation
and bacterial cell debris, and compartmentalization as the tree
attempts to isolate the pathogen (Kim et al., 2009; Koh et al.,
2012; Aritua et al., 2013). During our analysis of tissue samples
collected from HLB-infected seedlings, the highest expression
levels of L. asiaticus genes (post-treatment) was observed in tissue
collected from underdeveloped regions of the canopy, where leaf
growth was stagnate. Since the static growth of these branches
is indicative of severely obstructed vascular flow, it is possible
that the transport of small molecules (from the injection site)
to these regions of the tree was insufficient to deliver enough
chemical to completely inhibit the growth of L. asiaticus. As
such, the treatment of highly infected citrus trees may require
repeat injections or a combined application method that will
facilitate even distribution throughout the canopy tissue (such as
a foliar spray with adjuvants). Combined treatments with small
molecules and thermotherapy may also be a viable option, as
more efficient methods of heat treatment are developed.
There are very few antibiotics approved for use in the
treatment of plant diseases, and of those, only streptomycin
and tetracycline have shown minimal success in the treatment
of HLB, with tetracycline having phytotoxic effects at the
concentrations required for treatment of L. asiaticus. The
combined use of penicillin and streptomycin showed a
suppressive effect on L. asiaticus (Zhang et al., 2011), however,
the use of β-lactam antibiotics is highly regulated and
not approved for use in agriculture. As such, the use
of small molecules is a promising alternative to combat
L. asiaticus.
In this study, we were able to confirm that tolfenamic acid is
an effective inhibitor of L. asiaticus in planta. While additional
studies are needed to fully understand the recovery process of
treated trees, these encouraging results indicate the potential for
tolfenamic acid to be used as a systemic antimicrobial therapy
for HLB.
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